Skip to main content
23andMe Holding Co. (ME)
NASDAQ: ME · Real-Time Price · USD
0.340
+0.010 (3.00%)
At close: Sep 20, 2024, 4:00 PM
0.339
-0.001 (-0.35%)
After-hours: Sep 20, 2024, 6:52 PM EDT

23andMe Holding Co. Revenue

23andMe Holding Co. had revenue of $40.41M in the quarter ending June 30, 2024, a decrease of -33.60%. This brings the company's revenue in the last twelve months to $199.19M, down -32.67% year-over-year. In the fiscal year ending March 31, 2024, 23andMe Holding Co. had annual revenue of $219.64M, down -26.66%.

Revenue (ttm)
$199.19M
Revenue Growth
-32.67%
P/S Ratio
0.83
Revenue / Employee
$342,247
Employees
582
Market Cap
172.04M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024219.64M-79.85M-26.66%
Mar 31, 2023299.49M27.60M10.15%
Mar 31, 2022271.89M27.97M11.47%
Mar 31, 2021243.92M-61.54M-20.15%
Mar 31, 2020305.46M-135.44M-30.72%
Mar 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
High Tide 370.02M
The Joint 120.07M
Semler Scientific 61.74M
Compugen 42.72M
Capricor Therapeutics 27.15M
Stereotaxis 23.75M
Generation Bio Co. 13.17M
Lineage Cell Therapeutics 6.19M
Revenue Rankings

ME News

More News